Cargando…
Chloroquine/lopinavir/ritonavir/umifenovir: QTc interval prolongation, drug interaction and off-label use: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426387/ http://dx.doi.org/10.1007/s40278-020-82071-8 |
Ejemplares similares
-
Hydroxychloroquine/lopinavir/ritonavir: Vomiting and QTc-interval prolongation following off-label therapy: 2 case reports
Publicado: (2021) -
Lopinavir/ritonavir/umifenovir: Nausea, vomiting and diarrhoea following off-label treatment: case report
Publicado: (2021) -
Chloroquine: QTc prolongation following off-label use: case report
Publicado: (2022) -
Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021) -
Atazanavir/ritonavir: QTc prolongation following off-label treatment: case report
Publicado: (2021)